Begin_NGS

BeginNGS is a novel health care delivery system designed to screen newborns for genetic diseases — and connect their doctors with effective treatment options.

[Begin_NGS @Begin_NGS]

#BeginNGS is designed to screen #newborns for genetic diseases, connect doctors with effective treatment options & end the diagnostic odyssey. Through rapid #WholeGenomeSequencing, #raredisease can be diagnosed before symptoms appear.
#NewbornScreening
https://t.co/TF3SXkV8Rs

[Rady Genomics @RadyGenomics]

Welcome @Begin_NGS founding consortium member @sanofi. For 40+ yrs, Sanofi has been a pioneer of science & innovation, rallying its people & resources to help improve the lives of those living with #RareDisease. We thank Sanofi for its #BeginNGS support.
https://t.co/e2GB3j1BMe

[Rady Genomics @RadyGenomics]

Since our last Frontiers conference in 2019, there have been major advances in the world of genomic sequencing. At #GenomicFrontiers23, speakers from around the globe will share the latest research in #NewbornScreening & #WholeGenomeSequencing. Register: https://t.co/ylukB7CSwE

[Begin_NGS @Begin_NGS]

We had an inspiring time convening with the founding & prospective members of the @Begin_NGS consortium at #WORLDSymposia. Thank you to all who accompany us in our journey to help end the diagnostic & therapeutic odysseys.
#EndTheDiagnosticOdyssey #genomics #raredisease

[Rady Genomics @RadyGenomics]

In light of #RareDiseaseMonth, we thank our @Begin_NGS partner @EveryLifeOrg for joining our mission to screen newborns early for genetic diseases — and connect their doctors with effective interventions. Learn more: https://t.co/nbJb1O95FO

#RareDisease #genomics

[Begin_NGS @Begin_NGS]

Our team is looking forward to meeting up with both prospective and founding members of the @Begin_NGS consortium at @WORLDSymposia tomorrow. It's exciting to be working together to #endthediagnosticodyssey. #genomics #raredisease

[Lifebit @lifebitAI]

Today we’re excited to announce our new partnership with @Plumcare to support @BeginNGS_Greece & @RadyGenomics in Greece's new national pioneering newborn sequencing program. https://t.co/f1TUpWGsJr

[Rady Genomics @RadyGenomics]

The annual Frontiers in Pediatric Genomic Medicine Conference is back, both in person and online. This year's theme is "Taking Steps Towards Ending the Diagnostic Odyssey." Mark your calendars for April 19-20, 2023. Registration opens in February. https://t.co/hKvDURFxqG

[Rady Genomics @RadyGenomics]

Looking back at our 2022 highlights: the launch of our #BeginNGS newborn genomic screening initiative marked a major milestone. More in @sdut: https://t.co/qSV9xefZ1G
#NewbornScreening #WholeGenomeSequencing

[Rady Genomics @RadyGenomics]

Great blog by @APHL about the importance of #WholeGenomeSequencing & maintaining genetic privacy. The #newbornscreening community is adopting processes for request & approval, destruction, storage & documentation to have more transparency. https://t.co/AE9EUEoNIM
#RareDisease

[Rady Genomics @RadyGenomics]

Welcome to @Begin_NGS consortium member @orchard_tx, a company focused on new treatments that tap into the curative potential of HSC gene therapy. Thx for sharing in the vision to end the diagnostic odyssey.

https://t.co/yyD7ZYSQ7f
#RareDisease #WGS #NewbornScreening

[Rady Genomics @RadyGenomics]

ICYMI: Dr. Stephen Kingsmore & Catherine Nester of @inozyme were guests on the #RareDisease Report podcast. They discussed the role of #newbornscreening in diagnosing rare diseases + the impact @Begin_NGS can have on the future of rare disease medicine. https://t.co/pR8teeuPhh

[Innovative Hematology @innovativehem]

IHTC's Dr. Amy Shapiro discussed @Begin_NGS with WISHTV, an initiative she describes as a "quantum leap forward" in newborn screening. https://t.co/wW14cb4p16

#NewbornScreening #WholeGenomeSequencing #RareDisease #RapidPrecisionMedicine

[SeqComplete @SeqComplete]

#RareDisease Newborn Screening, Genetic Testing Varies by State - National Press Foundation | NPF https://t.co/goeppAzQSZ, see more https://t.co/8JJSArJY7K

[Rady Genomics @RadyGenomics]

Want to learn more about @Begin_NGS at #ASHG2022? Join Bill Mowrey of @AlexionPharma for “A genome sequencing system for universal #newbornscreening, diagnosis, & #precisionmedicine for severe genetic diseases.” Friday, 10/28, 2:45pm https://t.co/PFWHDfuvRH
#RareDisease

[Rady Genomics @RadyGenomics]

Thank you to @combined_brain for its support @Begin_NGS. COMBINEDBrain is a non-profit consortium devoted to speeding the path to clinical treatments for people with severe rare genetic, non-verbal, neurodevelopmental disorders.
#RareDisease #BeginNGS
https://t.co/LDoXljeHkk

[Rady Genomics @RadyGenomics]

Welcome to @Begin_NGS consortium member, Mahzi Therapeutics! We thank Mahzi for supporting the #BeginNGS pilot program & joining our mission to end the diagnostic odyssey. https://t.co/jXZaTBqt3L

#RareDisease #RapidPrecisionMedicine #NewbornScreening

[Rady Genomics @RadyGenomics]

Dr. Kingsmore joined Catherine Nester of @inozyme on the #RareDisease Report podcast. They discussed the role of #newbornscreening in diagnosing #rarediseases + the impact that @Begin_NGS can have on the future of rare disease medicine. #weekendlistening
https://t.co/pR8teeuPhh

[Begin_NGS @Begin_NGS]

A new article from Dr. Stephen Kingsmore shares the urgent need for extensive expansion of #NewbornScreening by genomic sequencing, the reasons why early attempts had limited success & how we're working to end the diagnostic & therapeutic odysseys. https://t.co/mmRshQgDN8

[Rady Genomics @RadyGenomics]

A big thank you to @EveryLifeOrg for their support of @Begin_NGS + our mission to end the diagnostic odyssey for neonatal & pediatric #raredisease. Learn more about this advocacy group here: https://t.co/nbJb1NQWrG
#BeginNGS #WholeGenomeSequencing #NewbornScreening

[Ultragenyx @ultragenyx]

We've announced our membership to the @Begin_NGS consortium to help improve #NewbornScreening. Eric Crombez, MD, Chief Medical Officer for Gene Therapy at Ultragenyx, shares his perspective on the importance of this program. Read the blog post: https://t.co/MI7JaFcGUp